Lithium augmentation therapy in refractory depression: clinical evidence and neurobiological mechanisms.
about
Lithium and genetic inhibition of GSK3beta enhance the effect of methamphetamine on circadian rhythms in the mouseThe co-administration of quetiapine or placebo to cognitive-behavior therapy in treatment refractory depression: a preliminary trial.Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder.An Evidence-Based Approach to Augmentation and Combination Strategies for: Treatment-Resistant Depression.Effects of different antidepressant treatments on the core of depression.Treatment strategies to improve and sustain remission in major depressive disorder.Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions.Therapy of treatment resistant depression: focus on the management of TRD with atypical antipsychotics.GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder.Augmentation and combination strategies for depression.Combination/augmentation strategies for improving the treatment of depression.MicroRNA-Mediated Regulation of ITGB3 and CHL1 Is Implicated in SSRI Action.Executive summary of the report by the WPA section on pharmacopsychiatry on general and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders.Depression in adults: drug and physical treatments
P2860
Q30435752-D9B68F6B-7699-4067-A902-2E0DC71E2F41Q33364299-3C165F21-F40B-4DE7-91A1-66B1448D6E28Q34146222-BA86C90B-1B39-4722-8A05-41A58555A5A6Q34220649-AAE7CF3F-3948-4785-AD72-10FC2F8C830CQ35237015-C7D2AEB0-95FD-4A7B-99A0-DA7EA319F24AQ35237047-4B2B4CA3-523E-4668-AE17-6F47EB5C4EABQ35748119-0045A9AD-F5A0-40BD-988A-384682A92FFEQ35936252-F8B991DE-0245-42FF-8F84-772AE3E52D36Q36062876-BA3FC73A-6A97-48A3-9163-D8A49A79AF85Q36462566-4445DD2A-29B4-4C54-A595-D795837A0651Q36713430-04E36FDF-E89E-4850-BF4F-B54DA502E7BAQ47118154-6C587BC8-28EA-4A28-9726-43B538E89E3FQ51498641-A7F4C2AC-1AB0-4536-94B8-0FA1D92BA495Q57542376-03FBB299-F23A-44CB-BA00-CEB2BD2F1257
P2860
Lithium augmentation therapy in refractory depression: clinical evidence and neurobiological mechanisms.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Lithium augmentation therapy i ...... nd neurobiological mechanisms.
@ast
Lithium augmentation therapy i ...... nd neurobiological mechanisms.
@en
type
label
Lithium augmentation therapy i ...... nd neurobiological mechanisms.
@ast
Lithium augmentation therapy i ...... nd neurobiological mechanisms.
@en
prefLabel
Lithium augmentation therapy i ...... nd neurobiological mechanisms.
@ast
Lithium augmentation therapy i ...... nd neurobiological mechanisms.
@en
P2093
P2860
P1476
Lithium augmentation therapy i ...... nd neurobiological mechanisms.
@en
P2093
Andreas Heinz
Anne Berghöfer
Johanna Sasse
Mazda Adli
Michael Bauer
Tom Bschor
P2860
P304
P356
10.1177/070674370304800703
P407
P577
2003-08-01T00:00:00Z